Recurrent Gallbladder Carcinoma With pMMR/MSS Achieved a Complete Response Following Camrelizumab Combined With Apatinib: A Case Report

Gallbladder carcinoma (GBC) with proficient mismatch repair (pMMR)/microsatellite stable (MSS) is associated with limited response to programmed death-1 (PD-1) inhibitor monotherapy. Limited data of PD-1 blockade combined with anti-angiogenic therapy in GBC are reported. One recurrent GBC patient wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Liting, Liu, Xiaoyu, Li, Zelei, Zhang, Xuebing, Wang, Yuli, Peng, Weiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792461/
https://www.ncbi.nlm.nih.gov/pubmed/35096582
http://dx.doi.org/10.3389/fonc.2021.783158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792461/
https://www.ncbi.nlm.nih.gov/pubmed/35096582
http://dx.doi.org/10.3389/fonc.2021.783158

Ejemplares similares